Nephrocare Health Services Limited (NEPHROPLUS) — Corporate Action
Nephrocare Health Services announced the allotment of 218,297 equity shares of ₹2 each to employees exercising stock options under the ESOP Scheme 2011, approved by the Nomination and Remuneration Committee on July 14, 2026. The issuance increased the paid-up capital from ₹20,06,81,434 to ₹20,11,18,028, with shares allotted on July 14, 2026 and listed on NSE and BSE following prior approvals. The shares rank pari-passu with existing shares and were issued at an exercise price totaling ₹2,08,18,944.35.
About Nephrocare Health Services Limited (NEPHROPLUS)
Healthcare · Healthcare Services · Listed on NSE
📡 Get AI alerts when NEPHROPLUS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NEPHROPLUS — Free💡 Ask AI about this filing
📊 More NEPHROPLUS filings
- 🟡 Board Meeting — 25 June 2026 Nephrocare Health Services Limited disclosed two board-approved financial support actions executed o...
- Announcement — 25 June 2026 Nephrocare Health Services announced it will acquire a dialysis center in Bataan, Philippines, for P...
- Announcement — 23 June 2026 Nephrocare Health Services announced it acquired a Philippine dialysis center through its subsidiary...
- 🟡 Board Meeting — 22 June 2026 The Board approved the NephroPlus Employee Stock Option Scheme 2026, authorizing up to 20,06,814 opt...
- regulation 31 — 19 June 2026 Edoras Investment Holdings Pte. Ltd, promoter of Nephrocare Health Services Limited, filed an annual...
🔥 Also filed on 15 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when NEPHROPLUS files new disclosures
Track NEPHROPLUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NEPHROPLUS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research